Potential Fish Oil as Acute Hepatitis Candidate by Hepatoprotective Mechanism: A-review

Heru Sasongko, Muhammad Fiqri Zulpadly, Yeni Farida

Abstract

Acute hepatitis is a health concern that emerged during the COVID-19 outbreak. Toxic drugs, infections, autoimmune diseases, and other causes may induce acute hepatitis, which is deadly. Acute hepatitis isn't treatable. Renewable natural products, such as fish, are used in complementary treatment. This paper mentions current preclinical and clinical studies of omega-3 fatty acids (N-3 FAs) for hepatoprotection. The mechanism of inhibition of oxidative stress and inflammation in the liver is the subject of discussion associated with its potential as a treatment for acute hepatitis. This review article on acute hepatitis treatment analyzed original articles, books, and other relevant material from the Web of Science, Scopus, and PubMed. The literature search was conducted in April-July 2022. The keywords explored during the literature investigation were "omega-3 or EPA or DHA or fish oil," "hepatoprotective," "acute hepatitis," "inflammatory", and "stress oxidative". The study's results show that N-3 FAs can protect against liver damage through inflammation and oxidative stress pathways. Enzyme parameters of liver damage, proinflammatory cytokines, and oxidative stress can be inhibited by the administration of fish oil and its derivatives. Even though not all clinical trial parameters are directly related to animal tests, the results of this study show that omega-3 fatty acids should be considered a treatment option for acute hepatitis.

Keywords

Acute hepatitis; inflammatory; omega‐3; stress oxidative

Full Text:

PDF

References

Abo El-Magd, N. F., El-Karef, A., El-Shishtawy, M. M., and Eissa, L. A. (2015). Hepatoprotective Effects of Glycyrrhizin and Omega-3 Fatty Acids on Nuclear Factor-Kappa B Pathway in Thioacetamide-Induced Fibrosis in Rats. Egyptian Journal of Basic and Applied Sciences, 2(2), 65-74. https://doi.org/10.1016/j.ejbas.2014.12.005

AbuMweis, S., Omran, D. A., Al-Shami, I., and Jew, S. (2021). The Ratio of Eicosapentaenoic Acid to Docosahexaenoic Acid as a Modulator for the Cardio-Metabolic Effects of Omega-3 Supplements: A Meta-Regression of Randomized Clinical Trials. Complementary Therapies in Medicine, 57, 102662.

AlAsmari, A. F., Alharbi, M., Alqahtani, F., Alasmari, F., AlSwayyed, M., Alzarea, S. I., Al-Alallah, I.A.,Alghamdi, A.,Hakami, H.M.,Alyousef, M.K.,Sari, Y.,and Ali, N. (2021). Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study. Antioxidants, 10(12), 1998. https://doi.org/10.3390/antiox10121998

Al-Attar, A. M., and Al-Rethea, H. A. (2017). Chemoprotective Effect of Omega-3 Fatty Acids on Thioacetamide Induced Hepatic Fibrosis in Male Rats. Saudi Journal of Biological Sciences, 24(4), 956-965. https://doi.org/10.1016/j.sjbs.2016.01.029

Al-Obaidi, W. M., and Al-Izzi, M. H. (2021). Effect of Different Types of Omega-3 Fish Oil on the Physiological, Biochemical and Immunological Parameters in Male Rabbits. Tropical Journal of Natural Product Research (TJNPR), 5(3), 434-439.

Baker, J. M., Buchfellner, M., Britt, W., Sanchez, V., Potter, J. L., Ingram, L. A., Shiau, H.,Sanchez, L.H.G.,Saaybi, S.,and Kelly, D. (2022). Acute Hepatitis and Adenovirus Infection among Children—Alabama, October 2021–February 2022. Morbidity and Mortality Weekly Report, 71(18), 638.

Basheer, A. S., Siddiqui, A., Paudel, Y. N., Hassan, M. Q., Imran, M., Najmi, A. K., and Akhtar, M. (2017). Hepatoprotective and Antioxidant Effects of Fish Oil on Isoniazid-Rifampin Induced Hepatotoxicity in Rats. PharmaNutrition, 5(1), 29-33. https://doi.org/10.1016/j.phanu.2017.01.002

Bataller, R., and Brenner, D. A. (2005). Liver Fibrosis. The Journal of clinical investigation, 115(2), 209-218.

Benzamin, M., Sayeed, M., Khadga, M., Nahid, K. L., Rukunuzzaman, M., Mazumder, M. W., Begum, F., Islam, M.S., Kibtiar, M., and Karim, A.B. (2019). Acute Hepatitis in Children: Experience at a Tertiary Hospital of Bangladesh. Pak Pediatr J, 43(4), 265-69.

Bruce, S. O., Onyegbule, F. A., Ezugwu, C. O., Nweke, I. D., Ezenwelu, C. R., and Nwafor, F. I. (2021). Chemical Composition, Hepatoprotective and Antioxidant Activity of the Crude Extract and Fractions of the Leaves of Fadogia cienkowskii Schweinf (Rubiaceae). Tropical Journal of Natural Product Research (TJNPR), 5(4), 720-731.

Chen, Y. H., Lou, J. G., Yang, Z. H., Chen, Q. J., Hua, C. Z., Ye, S., Zhang, C. M., Chen, J., Huang, Z. W., Yu, J. D., Gao, Z. G., and Shu, Q. (2022). Diagnosis, Treatment, and Prevention of Severe Acute Hepatitis of Unknown Etiology in Children. World Journal of Pediatrics, 18(8), 538-544

Daidj, N. B. B., and Lamri-Senhadji, M. (2021). Hepatoprotective and Anti-Obesity Properties of Sardine by-Product Oil in Rats Fed a High-Fat Diet. Preventive Nutrition and Food Science, 26(3), 285. https://doi.org/10.3746/pnf.2021.26.3.285

Elbarbary, N. S., Ismail, E. A. R., Farahat, R. K., and El-Hamamsy, M. (2016). ω-3 Fatty Acids as an Adjuvant Therapy Ameliorates Methotrexate-Induced Hepatotoxicity in Children and Adolescents with Acute Lymphoblastic Leukemia: A Randomized Placebo-Controlled Study. Nutrition, 32(1), 41-47.

El-Gendy, Z. A., El-Batran, S. A., Youssef, S. A. H., Ramadan, A., Hotaby, W. E., Bakeer, R. M., and Ahmed, R. F. (2021). Hepatoprotective Effect of Omega-3 PUFAs Against Acute Paracetamol-Induced Hepatic Injury Confirmed by FTIR. Human & Experimental Toxicology, 40(3), 526-537. https://doi.org/10.1177/0960327120954522

El-Mowafy, A. M., Abdel-Aziz, A. A., and Abdel-Dayem, M. A. (2022). Novel Protection by Omega-3-FAs (DHA or EPA) against Carbamazepine's Liver-Injury: Differential Suppression of Oxidative-Stress and Inflammatory Markers, and the Influence on Carbamazepine-Clearance. Clinical Nutrition Open Science, 42, 14-26.

Eraky, S. M., and El-Magd, N. F. A. (2020). Omega-3 Fatty Acids Protect Against Acetaminophen-Induced Hepatic and Renal Toxicity in Rats Through HO-1-Nrf2-BACH1 Pathway. Archives of Biochemistry and Biophysics, 687, 108387.

Feng, R., Wang, Y., Liu, C., Yan, C., Zhang, H., Su, H., Kang, J. X.,Shang, C. Z., and Wan, J. B. (2018). Acetaminophen-Induced Liver Injury is Attenuated in Transgenic Fat-1 Mice Endogenously Synthesizing Long-Chain N-3 Fatty Acids. Biochemical Pharmacology, 154, 75-88. https://doi.org/10.1016/j.bcp.2018.04.019

Gómez-Limia, L., Cobas, N., Franco, I., and Martínez-Suárez, S. (2020). Fatty Acid Profiles and Lipid Quality Indices in Canned European Eels: Effects of Processing Steps, Filling Medium and Storage. Food Research International, 136, 109601.

He, J., Bai, K., Hong, B., Zhang, F., and Zheng, S. (2017). Docosahexaenoic Acid Attenuates Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats. International Immunopharmacology, 53, 56-62. https://doi.org/10.1016/j.intimp.2017.09.013

Huang, H., Chang, Y. H., Xu, J., Ni, H. Y., Zhao, H., Zhai, B. W., Efferth, T.,Gu, C. B., and Fu, Y. J. (2022). Aucubin as a Natural Potential Anti-Acute Hepatitis Candidate: Inhibitory Potency and Hepatoprotective Mechanism. Phytomedicine, 102, 154170.

Igarashi, M., Ma, K., Chang, L., Bell, J. M., and Rapoport, S. I. (2007). Dietary n-3 PUFA Deprivation for 15 Weeks Upregulates Elongase and Desaturase Expression in Rat Liver But Not Brain. Journal of Lipid Research, 48(11), 2463-2470.

Janczyk, W., Lebensztejn, D., Wierzbicka-Rucińska, A., Mazur, A., Neuhoff-Murawska, J., Matusik, P., and Socha, P. (2015). Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial. The Journal of Pediatrics, 166(6), 1358-1363. https://doi.org/10.1016/j.jpeds.2015.01.056

Liu, J., Yeo, H. C., Overvik-Douki, E., Hagen, T., Doniger, S. J., Chu, D. W., Brooks, G. A., and Ames, B. N. (2000). Chronically and Acutely Exercised Rats: Biomarkers of Oxidative Stress and Endogenous Antioxidants. Journal of Applied Physiology, 89(1), 21-28.

Mariqueo, T. A., and Zúñiga-Hernández, J. (2020). Omega-3 Derivatives, Specialized Pro-Resolving Mediators: Promising Therapeutic Tools for the Treatment of Pain in Chronic Liver Disease. Prostaglandins, Leukotrienes and Essential Fatty Acids, 158, 102095.

Marsh, K., Tayler, R., Pollock, L., Roy, K., Lakha, F., Ho, A., David, H., Divala, T., Currie, S., Yirrell, D., Lockhart, M., Rossi, M. K., and Phin, N. (2022). Investigation Into Cases of Hepatitis of Unknown Aetiology Among Young Children, Scotland, 1 January 2022 to 12 April 2022. Eurosurveillance, 27(15), 2200318.

Nobili, V., Alisi, A., Della Corte, C., Risé, P., Galli, C., Agostoni, C., and Bedogni, G. (2013). Docosahexaenoic Acid for the Treatment of Fatty Liver: Randomised Controlled Trial in Children. Nutrition, Metabolism and Cardiovascular Diseases, 23(11), 1066-1070.

Nogueira, M. A., Oliveira, C. P., Alves, V. A. F., Stefano, J. T., dos Reis Rodrigues, L. S., Torrinhas, R. S., Cogliati, B., Barbeiro, H., Carrilho, F. J., and Waitzberg, D. L. (2016). Omega-3 Polyunsaturated Fatty Acids in Treating Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Clinical Nutrition, 35(3), 578-586. https://doi.org/10.1016/j.clnu.2015.05.001

Olayaki, L. A., Adeyemi, W. J., Yinusa, J. S., and Adedayo, G. A. (2018). Omega-3 Fatty Acids Moderate Oxidative and Proinflammatory Events in Experimental Hepatotoxicity in Wistar Rats: Comparison with Livolin. Synergy, 7, 17-24.

Pacifico, L., Bonci, E., Di Martino, M., Versacci, P., Andreoli, G., Silvestri, L. M., and Chiesa, C. (2015). A Double-Blind, Placebo-Controlled Randomized Trial to Evaluate the Efficacy of Docosahexaenoic Acid Supplementation on Hepatic Fat and Associated Cardiovascular Risk Factors in Overweight Children with Nonalcoholic Fatty Liver Disease. Nutrition, Metabolism and Cardiovascular Diseases, 25(8), 734-741.

Qiu, Y. D., Wang, S., Yang, Y., and Yan, X. P. (2012). Omega-3 Polyunsaturated Fatty Acids Promote Liver Regeneration After 90% Hepatectomy in Rats. World Journal of Gastroenterology: WJG, 18(25), 3288. https://doi.org/10.3748/wjg.v18.i25.3288

Raptis, D. A., Limani, P., Jang, J. H., Ungethüm, U., Tschuor, C., Graf, R., Humar, B., and Clavien, P. A. (2014). GPR120 on Kupffer Cells Mediates Hepatoprotective Effects of ω3-Fatty Acids. Journal of Hepatology, 60(3), 625-632.

Rashidi, M., Rashidmayvan, M., Alboativi, S., and Amiri, F. (2020). The Effect of Fish Oil Supplements on Serum Levels of Albumin, Lipid Profiles, and Kidney Function in Patients with Hypoalbuminemia Admitted to an Intensive Care Unit, Randomized Controlled Trial. PharmaNutrition, 13, 100197.

Refaie, A. A., Ramadan, A., Sabry, N. M., Khalil, W. K., and Mossa, A. T. H. (2021). Synthetic Insecticide Fipronil Induced Over Gene Expression, DNA and Liver Damage in Female Rats: the Protective Role of Fish Oil. Egyptian Journal of Chemistry, 64(5), 2325-2336. https://doi.org/10.21608/ejchem.2021.58506.3264

Saleh, D. O., Mahmoud, S. S., Hassan, A., and Sanad, E. F. (2022). Doxorubicin-Induced Hepatic Toxicity in Rats: Mechanistic Protective Role of Omega-3 Fatty Acids through Nrf2/HO-1 Activation and PI3K/Akt/GSK-3β Axis Modulation. Saudi Journal of Biological Sciences, 29(7), 103308. https://doi.org/10.1016/j.sjbs.2022.103308

Sallam, M., Mahafzah, A., Şahin, G. Ö., and ESCMID Study Group for Viral Hepatitis—(ESGVH). (2022). Hepatitis of Unknown Origin and Etiology (Acute Non HepA-E Hepatitis) Among Children in 2021/2022: Review of the Current Findings. In Healthcare, 10(6), 973. https://doi.org/10.3390/healthcare10060973

Sangouni, A. A., Orang, Z., and Mozaffari-Khosravi, H. (2021). Effect Of Omega-3 Supplementation on Fatty Liver and Visceral Adiposity Indices in Diabetic Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial. Clinical Nutrition ESPEN, 44, 130-135. https://doi.org/10.1016/j.clnesp.2021.06.015

Sasongko, H., Sugiyarto, S., Budiharjo, A., and Efendi, N. R. (2017). Anti-Hypercholesterolemia Effects and Quality Of Eel (Anguilla bicolor) Oil. In International Journal of Science and Applied Science: Conference Series, 2(1), 174-180. http://dx.doi.org/10.20961/ijsascs.v2i1.16704

Sasongko, H., and Sugiyarto, S. (2018). Pengaruh Pemberian Ekstrak Daun Karika (Vasconcellea pubescens A. DC.) terhadap Nilai SGPT dan SGOT pada Tikus Jantan yang Diinduksi Paracetamol. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 3(2), 70-75. http://dx.doi.org/10.20961/jpscr.v3i2.21796

Sasongko, H., Rahmawati, A. A., Farida, Y., and Sugiyarto, S. (2019). In-Vivo Antipyretic Effect of Eel (Anguilla bicolor bicolor) Oil on Yeast-induced Fever on Mice. ALCHEMY Jurnal Penelitian Kimia, 15(2), 219-227.

Sasongko, H., Nurrochmad, A., Nugroho, A. E.,and Rohman, A. (2022). Indonesian Freshwater Fisheries’ Oil For Health and Nutrition Applications: A Narrative Review. Food Research, 6(2), 501–511. http://dx.doi.org/10.26656/fr.2017.6(2).362

Scorletti, E., and Byrne, C. D. (2018). Omega-3 Fatty Acids and Non-Alcoholic Fatty Liver Disease: Evidence of Efficacy and Mechanism of Action. Molecular Aspects of Medicine, 64, 135-146. https://doi.org/10.1016/j.mam.2018.03.001

Shaaban, A. A., Shaker, M. E., Zalata, K. R., El-Kashef, H. A., and Ibrahim, T. M. (2014). Modulation of Carbon Tetrachloride-Induced Hepatic Oxidative Stress, Injury and Fibrosis by Olmesartan and Omega-3. Chemico-Biological Interactions, 207, 81-91.

Shalimar., Acharya, S. K., Kumar, R., Bharath, G., Rout, G., Gunjan, D., and Nayak, B. (2020). Acute Liver Failure of Non–AE Viral Hepatitis Etiology—Profile, Prognosis, and Predictors of Outcome. Journal of Clinical and Experimental Hepatology, 10(5), 453-461. https://doi.org/10.1016/j.jceh.2019.12.008

Shin, E. C., and Jeong, S. H. (2018). Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis A. Cold Spring Harbor Perspectives in Medicine, 8(9), a031708.

Shoieb, S. M., El-Ghiaty, M. A., Alqahtani, M. A., and El-Kadi, A. O. (2020). Cytochrome P450-Derived Eicosanoids and Inflammation in Liver Diseases. Prostaglandins & Other Lipid Mediators, 147, 106400.

van Beek, J., Fraaij, P. L., Giaquinto, C., Shingadia, D., Horby, P., Indolfi, G., Koopmans, M., and Acute Hepatitis Study Group. (2022). Case Numbers of Acute Hepatitis of Unknown Aetiology among Children in 24 Countries up to 18 April 2022 Compared to the Previous 5 Years. Eurosurveillance, 27(19), 2200370.

Wang, M., Zhang, X., Ma, L. J., Feng, R. B., Yan, C., Su, H., He, C., Kang, J. X., Liu, B., and Wan, J. B. (2017). Omega-3 Polyunsaturated Fatty Acids Ameliorate Ethanol-Induced Adipose Hyperlipolysis: A Mechanism for Hepatoprotective Effect Against Alcoholic Liver Disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1863(12), 3190-3201. https://doi.org/10.1016/j.bbadis.2017.08.026

Xu, Z., Li, Y., Wang, J., Wu, B., and Li, J. (2012). Effect of Omega-3 Polyunsaturated Fatty Acids to Reverse Biopsy-Proven Parenteral Nutrition-Associated Liver Disease in Adults. Clinical Nutrition, 31(2), 217-223. https://doi.org/10.1016/j.clnu.2011.10.001

Yamanushi, T. T., Kabuto, H., Hirakawa, E., Janjua, N., Takayama, F., and Mankura, M. (2014). Oral Administration of Eicosapentaenoic Acid or Docosahexaenoic Acid Modifies Cardiac Function And Ameliorates Congestive Heart Failure in Male Rats. The Journal of Nutrition, 144(4), 467-474.

DOI: https://doi.org/10.20961/jpscr.v8i2.68523

Refbacks

  • There are currently no refbacks.